Home/Acticor Biotech/Prof. Mikael Mazighi
PM

Prof. Mikael Mazighi

Co-Founder, Chief Medical Officer

Acticor Biotech

Therapeutic Areas

Acticor Biotech Pipeline

DrugIndicationPhase
Glenzocimab (ACT017)Acute Ischemic StrokePhase 2/3